Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension Trial to Investigate the Safety and Tolerability of Long-term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

NCT00498108 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00498108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00498108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension Trial to Investigate the Safety and Tolerability of Long-term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Lead sponsor
UCB Pharma
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
September 30, 2007
Enrollment
341 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic restless legs syndrome